WALTHAM, Mass., March 4, 2011 (GLOBE NEWSWIRE) -- BG Medicine (Nasdaq:BGMD) today announced that it will present at the 31 st Annual Cowen Health Care Conference on Tuesday, March 8, 2011 at 9:30 am EST. Pieter Muntendam, MD, President and Chief Executive Officer of BG Medicine will present on the company's behalf. The presentation will be available to the public through a webcast accessible via http://www.wsw.com/webcast/cowen3/bgmd/ or in the "Investors" section of the Company's website at www.bg-medicine.com. A replay of the presentation will be available on the company's website for 30 days.
About BG Medicine
BG Medicine is a life sciences company focused on the discovery, development, and commercialization of novel diagnostics based on biomarkers to improve patient outcomes and contain healthcare costs. BG Medicine recently launched the galectin-3 test for use in patients with heart failure. The galectin-3 test is the first novel blood test for cardiac disease cleared by the FDA in five years. For additional information about BG Medicine and galectin-3 testing, please visit www.bg-medicine.com and www.galectin-3.com .The BG Medicine Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=8765
CONTACT: Michael W. Rogers EVP & Chief Financial Officer (781) 890-1199